| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
|
Villanueva, C.
|
|
2011
|
47 |
7 |
p. 1037-1045
9 p.
|
article
|
| 2 |
Brachyury expression predicts poor prognosis at early stages of colorectal cancer
|
Kilic, Nerbil
|
|
2011
|
47 |
7 |
p. 1080-1085
6 p.
|
article
|
| 3 |
Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway
|
Yue, Pan
|
|
2011
|
47 |
7 |
p. 1115-1124
10 p.
|
article
|
| 4 |
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways
|
Rossi, Stefania
|
|
2011
|
47 |
7 |
p. 1095-1105
11 p.
|
article
|
| 5 |
Editorial board
|
|
|
2011
|
47 |
7 |
p. ii-
1 p.
|
article
|
| 6 |
Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1year follow-up
|
Corsetti, Vittorio
|
|
2011
|
47 |
7 |
p. 1021-1026
6 p.
|
article
|
| 7 |
Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations
|
Ganzinelli, M.
|
|
2011
|
47 |
7 |
p. 1086-1094
9 p.
|
article
|
| 8 |
First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes
|
Morak, Monika
|
|
2011
|
47 |
7 |
p. 1046-1055
10 p.
|
article
|
| 9 |
Increased cancer risks among arthroplasty patients: 30year follow-up of the Swedish Knee Arthroplasty Register
|
Wagner, Philippe
|
|
2011
|
47 |
7 |
p. 1061-1071
11 p.
|
article
|
| 10 |
Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects
|
Zou, Yan-Feng
|
|
2011
|
47 |
7 |
p. 1072-1079
8 p.
|
article
|
| 11 |
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2×2 randomised controlled trial
|
Kimman, M.L.
|
|
2011
|
47 |
7 |
p. 1027-1036
10 p.
|
article
|
| 12 |
Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: Case series, review and follow-up guidelines
|
Herkert, Johanna C.
|
|
2011
|
47 |
7 |
p. 965-982
18 p.
|
article
|
| 13 |
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas
|
Kummar, Shivaani
|
|
2011
|
47 |
7 |
p. 997-1005
9 p.
|
article
|
| 14 |
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
|
Schöffski, P.
|
|
2011
|
47 |
7 |
p. 1006-1012
7 p.
|
article
|
| 15 |
Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma
|
Duarte-Pereira, Sara
|
|
2011
|
47 |
7 |
p. 1106-1114
9 p.
|
article
|
| 16 |
Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes
|
Stenner, Markus
|
|
2011
|
47 |
7 |
p. 1013-1020
8 p.
|
article
|
| 17 |
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points
|
Wason, James M.S.
|
|
2011
|
47 |
7 |
p. 983-989
7 p.
|
article
|
| 18 |
Sociodemographic factors and incidence of melanoma in the Netherlands, 1994–2005
|
van der Aa, M.A.
|
|
2011
|
47 |
7 |
p. 1056-1060
5 p.
|
article
|
| 19 |
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803
|
Sargent, D.
|
|
2011
|
47 |
7 |
p. 990-996
7 p.
|
article
|
Journal description